FDA Approves Qfitlia™ (fitusiran) | Investor Relations | Alnylam Pharmaceuticals, Inc.

Global English
- AustriaDeutsch
- BelgiumNederlands Français
- BrazilPortuguês
- CanadaFrançais English
- DenmarkDansk
- FranceFrançais
- GermanyDeutsch
- IrelandEnglish
- ItalyItaliano
- Japan日本語
- LuxembourgFrançais Deutsch
- NetherlandsNederlands
- PortugalPortuguês
- SpainEspañol
- SwedenSvenska
- SwitzerlandFrançais Deutsch Italiano
- Taiwan繁體中文
- United KingdomEnglish

FDA Approves
Qfitlia™ (fitusiran)

In partnership with Sanofi, this is our 6th Alnylam-discovered approval in the U.S.

qfitlia news-letter top-alinged

Our Science Green dna

17